The Impact of Warfarin on Patients with End Stage Renal Disease

Table 1

Comparison of the demographics and comorbidities of patients with end stage renal disease with and without warfarin from the 2005–2010 National Inpatient Sample.

	ESRD with warfarin	ESRD without warfarin
Number	32,737	895,077
	Demographics
Age in years ± SD	64.1 ± 15.7	61.1 ± 16.1	<0.001
Female (%)	49.0%	48.0%	NS
Caucasian (%)	54.6%	42.8%	<0.001
	Comorbid conditions
Amputation	4.6%	3.6%	<0.001
CHF	23.0%	21.0%	<0.001
COPD	21.0%	18.0%	<0.001
CVA	7.9%	3.8%	<0.001
DM	28.0%	25.0%	<0.001
HTN	76.0%	75.0%	<0.001
MI	8.6%	6.0%	<0.001
PVD	16.0%	15.0%	<0.001
Valve	13.0%	5.0%	<0.001